Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.

Pyronaridine

Small molecule · Inhibitor · developed by Shin Poong Pharmaceutical Co.

Phase 1 Most advanced trial

What is Pyronaridine?

Pyronaridine is a benzonaphthyridine derivative with antimalarial activity. It inhibits formation of beta-hematin, causing toxic heme to accumulate within the parasite and promoting hematin-induced lysis of red blood cells, which leads to parasite death. It also shows in vitro antiviral activity against Ebola virus and SARS-CoV-2.

Summary written with AI from the sources listed at the end of this page.

At a glance

Drug type
Small molecule
Mechanism
Inhibitor
Pathways
heme detoxification, beta-hematin formation, glutathione-dependent hematin degradation
Therapy area
Infectious disease
Developer
Shin Poong Pharmaceutical Co. Ltd.
In trials of
MRK
FDA status
Investigational, not approved in the US. Most advanced trial: Phase 1
UNII
TD3P7Q3SG6

Conditions studied

Healthy

Sources

Updated Nov 8, 2026.

Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.